Neogenomics Inc (NEO)

Jan 15, 2025, 7:05 AM EST - 2 days ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Jan 10, 2025, 7:05 AM EST - 7 days ago

NeoGenomics Announces Chief Executive Officer Succession

Jan 6, 2025, 7:55 AM EST - 11 days ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 8:05 AM EST - 5 weeks ago

NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

Dec 9, 2024, 8:10 AM EST - 5 weeks ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

Dec 5, 2024, 7:00 AM EST - 6 weeks ago

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

Nov 19, 2024, 8:15 AM EST - 2 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Nov 14, 2024, 8:10 AM EST - 2 months ago

Felicia Williams Joins NeoGenomics Board of Directors

Nov 8, 2024, 7:00 AM EST - 2 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 5, 2024, 1:27 PM EST - 2 months ago

NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 2 months ago

NeoGenomics Reports Third Quarter 2024 Results

Oct 22, 2024, 8:10 AM EDT - 3 months ago

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

Oct 15, 2024, 7:30 AM EDT - 3 months ago

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

Oct 8, 2024, 8:10 AM EDT - 3 months ago

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

Oct 2, 2024, 12:10 PM EDT - 3 months ago

NeoGenomics Inc (NEO) Shares Up 3.95% on Oct 2

Sep 23, 2024, 6:47 PM EDT - 4 months ago

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

Sep 11, 2024, 8:05 AM EDT - 4 months ago

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Aug 29, 2024, 8:05 AM EDT - 5 months ago

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Jul 29, 2024, 8:14 PM EDT - 6 months ago

NeoGenomics, Inc. (NEO) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 4:05 PM EDT - 6 months ago

NeoGenomics Reports Second Quarter 2024 Results

Jul 9, 2024, 7:00 AM EDT - 6 months ago

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Jun 13, 2024, 8:00 AM EDT - 7 months ago

Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month

Jun 10, 2024, 1:00 AM EDT - 7 months ago

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

FLGT

May 28, 2024, 8:05 AM EDT - 8 months ago

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

Apr 30, 2024, 2:11 PM EDT - 9 months ago

NeoGenomics, Inc. (NEO) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 7:30 AM EDT - 9 months ago

NeoGenomics Reports First Quarter 2024 Results

Apr 18, 2024, 7:05 AM EDT - 9 months ago

NeoGenomics Announces Senior Leadership Promotions

Apr 9, 2024, 7:00 AM EDT - 10 months ago

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

Mar 27, 2024, 8:30 AM EDT - 10 months ago

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

Mar 20, 2024, 7:00 AM EDT - 10 months ago

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

Mar 1, 2024, 7:05 AM EST - 11 months ago

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 21, 2024, 7:02 PM EST - 11 months ago

NeoGenomics stock surged but technicals point to a pullback

Feb 20, 2024, 7:20 PM EST - 11 months ago

NeoGenomics, Inc (NEO) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 4:05 PM EST - 11 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

Feb 1, 2024, 7:05 AM EST - 1 year ago

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

Jan 30, 2024, 7:05 AM EST - 1 year ago

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

Jan 2, 2024, 7:05 AM EST - 1 year ago

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 8:10 AM EST - 1 year ago

NeoGenomics to Appeal Ruling

Dec 5, 2023, 8:00 AM EST - 1 year ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

Nov 14, 2023, 7:00 AM EST - 1 year ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

Nov 6, 2023, 8:03 PM EST - 1 year ago

NeoGenomics, Inc (NEO) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 1 year ago

NeoGenomics Reports Third Quarter 2023 Results

Oct 24, 2023, 7:00 AM EDT - 1 year ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

Oct 17, 2023, 9:20 AM EDT - 1 year ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Aug 8, 2023, 3:35 PM EDT - 1 year ago

NeoGenomics, Inc (NEO) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 7:00 AM EDT - 1 year ago

NeoGenomics Reports Second Quarter 2023 Results

Jul 27, 2023, 7:00 AM EDT - 1 year ago

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

Jul 18, 2023, 7:10 AM EDT - 1 year ago

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

Jul 18, 2023, 1:00 AM EDT - 1 year ago

Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery